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A balanced t(1;11) translocation that directly disrupts DISC1 is linked to schizophrenia and 46 
affective disorders. We previously showed that a mutant mouse, named Der1, recapitulates 47 
the effect of the translocation upon DISC1 expression. Here, RNAseq analysis of Der1 48 
mouse brain tissue found enrichment for dysregulation of the same genes and molecular 49 
pathways as in neuron cultures generated previously from human t(1;11) translocation 50 
carriers via the induced pluripotent stem cell route. DISC1 disruption therefore apparently 51 
accounts for a substantial proportion of the effects of the t(1;11) translocation. RNAseq and 52 
pathway analysis of the mutant mouse predict multiple Der1-induced alterations converging 53 
upon synapse function and plasticity. Synaptosome proteomics confirmed that the Der1 54 
mutation impacts synapse composition, and electrophysiology found reduced AMPA:NMDA 55 
ratio in hippocampal neurons, indicating changed excitatory signalling. Moreover, 56 
hippocampal Parvalbumin-positive interneuron density is increased, suggesting that the 57 
Der1 mutation affects inhibitory control of neuronal circuits. These phenotypes predict that 58 
neurotransmission is impacted at many levels by DISC1 disruption in human t(1;11) 59 
translocation carriers. Notably, genes implicated in schizophrenia, depression and bipolar 60 
disorder by large-scale genetic studies are enriched among the Der1-dysregulated genes, 61 
just as we previously observed for the t(1;11) translocation carrier-derived neurons. 62 
Furthermore, RNAseq analysis predicts that the Der1 mutation primarily targets a subset of 63 
cell types, pyramidal neurons and interneurons, previously shown to be vulnerable to the 64 
effects of common schizophrenia-associated genetic variants. In conclusion, DISC1 65 
disruption by the t(1;11) translocation may contribute to the psychiatric disorders of 66 
translocation carriers through commonly affected pathways and processes in 67 
neurotransmission.   68 





Psychiatric illnesses such as schizophrenia and recurrent affective disorders have a 71 
substantial underlying genetic component. Considerable progress has been made in recent 72 
years towards identification of the multitude of genes involved using large-scale studies of 73 
genome-wide association (GWAS) and recurrent copy number variants (CNVs)1-6. GWAS 74 
tends to identify genomic loci with common, but small, individual effects that encompass 75 
several genes, leaving the specific causal genes unidentified, unless further refinements are 76 
applied. In contrast, recurrent CNVs are rare, tending to exert a strong effect (most likely due 77 
to large changes in expression levels of the genes at fault), but also usually encompass 78 
multiple genes. Chromosomal rearrangements, such as translocations, linked to psychiatric 79 
disorders are rarer still, but can have the advantage of strong effects and accurate 80 
pinpointing of genes due to their disruption by the breakpoints of the rearranged genomic 81 
segments. It is likely that convergence of data arising from genomic events such as these 82 
will assist in revealing the genes and mechanisms that predispose to major mental illness. 83 
One example of a chromosomal rearrangement linked to psychiatric disorders is a 84 
t(1;11) translocation that substantially increases risk of developing schizophrenia or affective 85 
disorders in a large Scottish family7-9. The psychiatric symptoms presented by t(1;11) 86 
translocation carriers are typical, that is, they are within the range of current diagnostic 87 
criteria, and are accompanied by reduced white matter integrity10, cortical thickness11 and 88 
prefrontal cortex gyrification9, all typical of schizophrenia. Carriers of the t(1;11) translocation 89 
also have decreased glutamate levels in the dorsolateral prefrontal cortex9. Moreover, 90 
transcriptome analysis of induced pluripotent stem cell (IPSC)-derived cortical neurons from 91 
t(1;11) translocation carriers12 found enrichment for dysregulated genes at putative 92 
schizophrenia and depression loci discovered through large scale GWAS and CNV studies1-93 
3, potentially identifying some of the genes of interest at those loci, and indicating that the 94 
t(1;11) translocation may trigger disease pathways shared with schizophrenic patients who 95 




 The t(1;11) translocation directly disrupts the DISC1 gene on chromosome 113. 97 
DISC1 encodes a potential molecular scaffold protein involved in multiple critical functions in 98 
the developing and adult brain14, 15, including neurogenesis16-18, neuronal cargo trafficking19-23 99 
and neurotransmission23-26. DISC1 disruption is therefore likely to contribute substantially to 100 
mechanisms leading to psychiatric illness in t(1;11) translocation carriers. 101 
Two apparently non-coding genes of unknown function, DISC2 and DISC1FP1 102 
(otherwise known as Boymaw), are also disrupted on chromosomes 1 and 11, respectively13, 103 
27, and potential genetic modifier loci have been identified within the family28, all of which 104 
may additionally impact disease mechanisms in t(1;11) translocation carriers. It is now 105 
important to discover how each of these disruptions and putative modifiers relate to the gene 106 
expression changes, brain structure alterations and psychiatric symptoms of t(1;11) 107 
translocation carriers.  108 
To examine the impact of DISC1 disruption in isolation from the additional 109 
complexities of DISC2 disruption and loss of normal DISC1FP1 function, and of potential 110 
genetic modifiers, we have utilised a mutant mouse which accurately recapitulates the 111 
effects of the translocation upon DISC1 expression12. IPSC-derived neural precursor cells 112 
and cortical neurons from t(1;11) translocation carriers exhibit reduced DISC1 expression12. 113 
Chimeric transcripts encoding aberrant C-terminally truncated chimeric forms of DISC1 are 114 
also produced in the IPSC-derived neural cells as a result of fusion between the DISC1 and 115 
DISC1FP1 genes on the derived chromosome 112, 29. The mutant mouse was precisely 116 
engineered to mimic the fusion between DISC1 and DISC1FP1 on the derived 1 117 
chromosome and exhibits reduced Disc1 levels plus chimeric transcript expression12. This 118 
mutant mouse is referred to as Der1. 119 
Heterozygous Der1 mice express reduced levels of wild-type Disc1 plus the aberrant 120 
chimeric transcripts12, 29. Because Disc1 multimerises30, there is thus potential in 121 
heterozygotes for dominant-negative effects due to interaction between wild-type and mutant 122 
Disc1. Homozygotes, however, lack any wild-type Disc1 and may express high levels of 123 




carriers, we opted to study both mutant genotypes in order to obtain the most complete 125 
understanding of the likely effects of DISC1 disruption. A flow chart (Supplementary Figure 126 
1) illustrates the experimental approach taken, with the aim of allowing the results described 127 
here to be compared with previously published t(1:11) translocation studies and integrated 128 
with psychiatric genetic association studies of single nucleotide polymorphism (SNP) and 129 
CNV variants in the general population. We combine magnetic resonance imaging (MRI), 130 
histology, transcriptomics, synaptosome proteomics and electrophysiology to demonstrate 131 
that the Der1 mutation primarily affects cellular properties rather than brain structure, and 132 
that it targets a variety of cell types including neurons. Patterns of gene expression and 133 
predictions of altered biological processes substantially overlap between Der1 cortex and 134 
IPSC-derived cortical neuron cultures from t(1:11) translocation carriers. We find widespread 135 
dysregulation of genes implicated as potential common risk factors for schizophrenia, 136 
depression and bipolar disorder. We therefore propose that DISC1 disruption targets 137 
common pathways shared with psychiatric patients who do not carry the t(1;11) 138 
translocation, to contribute to the elevated risk of major mental illness displayed by t(1:11) 139 
translocation carriers9. 140 
 141 
Materials and methods 142 
Detailed materials and methods are provided in the Supplementary information file. 143 
 144 
Results 145 
Adult Der1 mutant mice show no overt changes in brain structure 146 
Using ex vivo structural MRI, we found no evidence for effects of the Der1 mutation on 147 
overall brain volume or the volumes of 51 brain regions analysed individually 148 
(Supplementary Table 1). In the absence of hypotheses arising from the MRI analysis of 149 
brain structure, and given that DISC1 is highly expressed in the hippocampus from early 150 
development through to adulthood, and that prefrontal cortex (PFC) is affected in t(1:11) 151 




not affect cell densities in the hippocampal Stratum, Radiatum, Lacunosum and Moleculare 153 
or prefrontal cortex, nor the thickness of individual cortical layers within the barrel cortex, nor 154 
the total cortical thickness in either the barrel cortex or the PFC (Supplementary Figure 2, 3, 155 
4). 156 
 157 
RNAseq analysis of adult Der1 cortex and hippocampus 158 
We next conducted RNASeq using wild-type and heterozygous ‘cortex’ (consisting of 159 
cortices minus hippocampus, cerebellum and olfactory bulbs) and hippocampus. The 160 
resulting data were analysed at the whole gene and single exon levels using DESeq231 and 161 
DEXSeq32, respectively. Full-length Disc1 expression is reduced in heterozygous Der1 162 
mouse whole brain as detected by quantitative RT-PCR and immunoblotting12. RNAseq also 163 
found reduced Disc1 expression in heterozygous Der1 cortex and hippocampus (Figure 1a, 164 
Supplementary Table 2a, c), confirming the validity of these datasets.  165 
Expression of 30,121 genes was detected in cortex, of which 2,124 and 3,568 are 166 
differentially expressed in heterozygotes at the whole gene or exon level respectively (all 167 
corrected p<0.05, Figure 1b, Supplementary Table 2a, b). Expression of 28,049 genes was 168 
detected in hippocampus, of which 175 and 52 are differentially expressed in heterozygotes 169 
at the whole gene or exon level respectively (all adjusted p<0.05, Supplementary Table 2c, 170 
d).  171 
 172 
Expression Weighted Cell-type Enrichment (EWCE) analysis of RNASeq data 173 
suggests specific cell types are targeted by the Der1 mutation 174 
EWCE analysis33 was used to look for evidence that certain cell types are especially 175 
vulnerable to the Der1 mutation. We utilised gene expression profiles generated by 176 
hierarchical clustering of single cell RNASeq profiles from 9,970 mouse brain cells and 177 
around 15,000 of the most abundantly expressed genes, resulting in 24 cell classes, referred 178 
to as the KI Superset34. The authors of that study calculated ‘specificity values’ for each 179 




compared to the other classes in the Superset34. EWCE analysis was used here to 181 
determine whether there is enrichment for Der1-induced dysregulation of genes with high 182 
specificity values for Superset cell classes in cortex (Figure 1c). Statistical significance was 183 
observed for pyramidal neurons (‘pyramidal somatosensory’, ‘pyramidal CA1’ [which also 184 
encompasses neurons from CA2 and the subiculum34]), interneurons (‘cortical interneuron’, 185 
‘striatal interneuron’), dopaminergic neurons (‘dopaminergic adult neurons’, ‘hypothalamic 186 
dopaminergic neurons’), ‘oxytocin/vasopressin-expressing neurons’ and 187 
‘astrocytes/ependymocytes’. Der1 hippocampus dysregulated genes are also highly 188 
enriched in several cell classes (Figure 1d). Of these, pyramidal neurons (‘pyramidal 189 
somatosensory’), ‘medium spiny neuron’ and ‘interneuron’ achieved statistical significance. 190 
‘Pyramidal CA1’ reached initial significance in Der1 hippocampus, but did not survive 191 
multiple testing correction. Pyramidal CA1, pyramidal somatosensory and medium spiny 192 
neurons should reside primarily in the hippocampus, cortex and striatum, respectively, thus 193 
some of these findings were initially unexpected. However, the previously published 194 
hierarchical clustering of cell classes34 indicated that ‘pyramidal CA1’ and ‘pyramidal 195 
somatosensory’ are highly similar, with medium spiny neurons the next most closely related 196 
cell type. We therefore infer that in cortex and hippocampus the Der1 mutation may target 197 
general features shared between these three neuron classes. 198 
Based on these findings, Parvalbumin-expressing interneuron density was quantified 199 
in adult PFC and hippocampus. PFC shows no change (Supplementary Figure 5), however 200 
there is a trend towards an increase in the dentate gyrus (p=0.07), and a significant increase 201 
in Der1 heterozygotes when the whole hippocampus is examined (34% increase, Figure 1e, 202 
f). The EWCE analysis data pointing to hippocampal interneuron targeting could therefore be 203 
due, at least partially, to increased density of interneurons expressing Parvalbumin at high 204 
levels. This contrasts with previous reports of reduced Parvalbumin-positive cell density in 205 
mice expressing mutant DISC1, or in response to endogenous Disc1 knockdown35. 206 
We also hypothesised that the cell types most affected by the Der1 mutation might 207 




hippocampal regions examined, there is a trend towards increased apoptosis in CA1 209 
(p=0.06, Supplementary Figure 6), which may indicate that CA1 cells are particularly 210 
vulnerable. This could lead to reduced cell density in CA1, a parameter that unfortunately 211 
could not be adequately examined due to the prohibitively tight packing of cells in this region.  212 
 213 
RNASeq deconvolution suggests that cell class proportions are unaltered by the Der1 214 
mutation 215 
RNASeq deconvolution was carried out utilising gene expression data (rather than the 216 
specificity values used above for EWCE analysis) for the most highly enriched genes from 217 
the 24 cell classes of the Superset34. First, the ability of the deconvolution programme, 218 
CIBERSORT36, to deconvolve the 24 cell classes was examined by generating artificial in 219 
silico samples with varying proportions of each cell class (Supplementary Figure 7). Using 220 
two specificity value thresholds, CIBERSORT was able to deconvolve most cell types. The 221 
exceptions include embryonic cell types, which should be absent from our Der1 samples, 222 
and rarer cell types in adult brain such as neural progenitors and neuroblasts. When used to 223 
deconvolve Der1 cortex and hippocampus whole gene DESeq2 RNASeq data, CIBERSORT 224 
found no evidence for an effect of the mutation upon the relative proportion of any of the cell 225 
classes examined (Supplementary Figure 8). The increased density of hippocampal 226 
Parvalbumin-positive interneurons (Figure 1e, f) therefore may not represent a general effect 227 
upon all hippocampal interneuron types. Likewise, the trend towards increased hippocampal 228 
CA1 apoptosis (Supplementary Figure 6) does not translate to a detectably decreased 229 
density of pyramidal CA1 neurons, possibly because this Superset class also contains 230 
pyramidal neurons from CA2 and the subiculum34. 231 
 232 
Molecular pathway analysis predicts wide-ranging effects of the Der1 mutation 233 
Since the patterns of gene dysregulation are not explained by overtly altered cell 234 
proportions, the RNASeq data were next used to predict effects upon canonical pathways. 235 




using statistical significance and magnitude plus direction of fold-change, was carried out 237 
using the whole gene level DESeq2 data, or combined DESeq2 plus exon level DEXSeq 238 
data. This analysis predicts effects upon diverse pathways including metabolic, stress-239 
response and important neurosignalling processes (Figure 2a). A selection of these 240 
pathways, based on statistical significance or relevance to later parts of this study, are 241 
discussed below. 242 
Mitochondrial dysfunction, including increased oxidative phosphorylation is strongly 243 
predicted, based largely upon upregulated whole gene expression of multiple complex I, III 244 
and IV components (Supplementary Figure 9), consistent with DISC1’s known role in 245 
regulating oxidative phosphorylation37, 38. Moreover, the chimeric transcripts expressed by 246 
Der1 mice encode aberrant mitochondrial species that induce mitochondrial dysfunction29. 247 
Also upregulated at the whole gene level is the mitochondrial pathway ‘Fatty acid -248 
oxidation I’ (Supplementary Figure 10) which degrades fatty acids to release energy. 249 
Dysregulated enzymes feeding into this pathway are involved in fatty acid synthesis and 250 
break down. Together these changes imply altered levels of lipids, which are critical for 251 
many brain processes. 252 
The ‘CREB signalling in neurons’ pathway (Figure 2b) is activated by cell surface 253 
glutamate receptors, including AMPA and NMDA receptors, and calcium channels. It 254 
regulates gene expression changes that are critical for synaptic plasticity and long-term 255 
potentiation (LTP), both known to be DISC1-modulated30. DISC1 is also already known to 256 
regulate CREB signalling30, and in our study IPA predicts that downregulation of Creb1 257 
activity is responsible for many of the gene expression changes (p=9e-9, z=-3). Indeed, 258 
there is enrichment (hypergeometric p=0.02) for dysregulation of genes containing 259 
conserved cAMP-Response Elements (CREs, http://natural.salk.edu/creb/, Supplementary 260 
Table 3) in heterozygous Der1 cortex, with 203 (9.6%) of the genes dysregulated at the 261 
whole gene level having CREs. The Der1 mutation potentially affects activation of the 262 
pathway via AMPA receptor subunit degradation39, and NMDA receptor membrane 263 




including AMPA and NMDA receptor subunits, and several synaptic scaffolds are 265 
dysregulated (Figure 2b). 266 
 Using the combined dysregulated DESeq2 plus DEXSeq data, IPA also determined 267 
that many cellular functions are enriched for differentially expressed genes (Table 1, 268 
Supplementary Table 4a). Predictions relating to neurotransmission, synaptic plasticity and 269 
LTP are related to the ‘CREB signalling in neurons’ pathway above, plus genes encoding 270 
inhibitory signalling factors, such as subunits of GABAA and GABAB receptors. Predictions 271 
relating to vesicle transport and exo/endocytosis are based on dysregulated genes encoding 272 
vesicle trafficking factors; voltage-gated calcium channel subunits as well as synaptotagmins 273 
and syntaxins that together mediate calcium-dependent neurotransmitter release; 274 
components of the exocyst complex; and components of the endocytic Clathrin-associated-275 
Adaptor-Protein-Complex. The wide-ranging neuronal morphology and cytoskeleton-related 276 
predictions are based on multiple genes involved in diverse relevant processes. Similarly, 277 
the cell-cell contact/adhesion-related functions are widespread, but notably encompass 278 
genes required for early synapse formation, such as latrophilins, as well as maintenance of 279 
trans-synaptic connections, for example neuroligins and neurexins. Other predictions relate 280 
to cell proliferation, neuronal migration and circadian rhythms. All of these processes are 281 
already known to involve DISC112, 16, 18, 21, 25, 35, 40-43. 282 
Der1 hippocampus RNASeq data were similarly analysed. IPA did not strongly 283 
predict any canonical pathway changes due to the relatively small number of changes, but 284 
did predict altered functions that largely reflect those for cortex (Supplementary Table 4b, 5), 285 
and there is enrichment for dysregulation of 86 shared genes (39% of the total dysregulated 286 
hippocampal genes, Supplementary Table 2c, d) in both regions (p=7e-11). Myelination is 287 
also predicted to be affected, consistent with previous studies demonstrating DISC1 288 
involvement in oligodendrocyte differentiation and function44-46. 289 
Numerous processes are thus predicted to be affected by the Der1 mutation in cortex 290 





Molecular pathway analysis of targeted cell types identified by EWCE analysis 293 
EWCE analysis identified cell classes that may be targeted by the Der1 mutation (Figure 1c, 294 
d). We reasoned that the cell class-enriched gene expression changes may inform on the 295 
impact of the Der1 mutation in each cell type. Pathway analysis was therefore carried out 296 
using the cell class-enriched dysregulated genes (Supplementary Table 6, 4c). Der1 cortex 297 
pyramidal neuron (CA1 and somatosensory) and interneuron terms relate to synaptic 298 
transmission. Der1 cortex astrocyte/ependymocyte terms relate to lipid metabolism and 299 
uptake of glutamine/glutamate. The lipid metabolism predictions are based on upregulation 300 
of genes encoding enzymes involved in fatty acid -oxidation, and other aspects of brain 301 
lipid metabolism. This is related to the Der1 cortex RNASeq canonical pathway prediction 302 
‘Fatty Acid -oxidation I’ (Figure 2a), and indicates a potential imbalance between lipid 303 
synthesis and oxidation. Since astrocytes are a major source of brain lipid which is widely 304 
utilised, including for synapse function47 and myelination by oligodendrocytes48, these 305 
processes may be compromised via astrocyte dysfunction. The glutamine/glutamate uptake 306 
predictions are based on dysregulated expression of genes such as Slc1a2, which encodes 307 
the synaptic glutamate transporter Eaat2. Astrocytes are critical regulators of glutamine and 308 
glutamate homeostasis in the brain, which includes glutamate clearance from synapses, and 309 
consequent regulation of glutamatergic neurotransmission and synaptic plasticity49. There 310 
were no convincing findings for the other cell classes examined. 311 
 312 
Shared gene dysregulation in heterozygous Der1 cortex and t(1:11) translocation 313 
carrier-derived cortical neuron cultures confirms the relevance of the Der1 RNASeq 314 
findings to psychiatric illness 315 
To determine how the above RNASeq data analyses of the Der1 mouse relate to the t(1:11) 316 
translocation, we compared the Der1 mouse data to previously published RNASeq data 317 
generated from t(1:11) translocation carrier-derived neuron cultures12. Human IPSC-derived 318 




trend towards enrichment for shared gene expression changes was evident from the 20 320 
dysregulated genes in common between IPSC-derived cortical neuron cultures from t(1:11) 321 
translocation carriers12 and heterozygous Der1 hippocampus (p=0.06, Supplementary Table 322 
2c, d), while 511 genes are differentially expressed in both heterozygous Der1 mouse cortex 323 
and the IPSC-derived cortical neuron cultures (Supplementary Table 2a, b), demonstrating 324 
significant enrichment (p=1e-14), and further validating the Der1 mouse as an accurate 325 
model for the effect of the t(1:11) translocation upon DISC1 expression. An overlapping set 326 
of cellular functions were also identified in the human cortical neuron cultures and 327 
heterozygous Der1 mouse cortex (Table 1, Supplementary Table 4a, d). Moreover, for most 328 
of the shared functions there is either significant enrichment or a trend towards enrichment 329 
for a common set of differentially expressed genes (Table 1). This convergence indicates 330 
that disruption of DISC1 likely contributes substantially to the altered molecular pathways in 331 
the human neuron cultures. 332 
Nonetheless, several functions are enriched in the Der1 cortex data, but not in the 333 
human cortical neuron data. Many relate specifically to synaptic plasticity and LTP, 334 
processes that are constitutive in brain, but which require stimulation to be detected in 335 
neuronal cultures. A number of other changes relate specifically to development of 336 
dendrites, which may not reach maturity in IPSC-derived neuronal cultures50. 337 
 338 
Mass spectrometry and SynGO analysis of adult Der1 synaptosomes confirm synaptic 339 
changes 340 
To complement the RNASeq analysis, synaptosome fractions were prepared from hetero- or 341 
homozygous Der1 mice and mass spectrometry was used to determine whether 342 
synaptosomal protein expression profiles differ between mutant and wild-type mice. Of the 343 
2,783 detected proteins in cortex, no changes survived multiple correction testing in 344 
synaptosomes prepared from Der1 mice (Supplementary Table 7a, Supplementary Figure 345 
11). Of the 2,183 proteins detected in hippocampus, 62 were found to be dysregulated in 346 




Figure 11). These proteins were annotated to well-established synaptic genes using the 348 
SynGO database51 (Figure 2c, Supplementary Table 7c). This is an expert-curated database 349 
of gene ontology terms relating to synapses. From the 62 regulated proteins, 26 were found 350 
annotated in SynGO, 24 with cellular component annotation and 19 with biological 351 
processes annotation. Dysregulated proteins were found annotated across a wide spectrum 352 
of pre- and post-synapse functions. For instance, several proteins were annotated to the 353 
postsynaptic density, such as Camk2a (downregulated); AMPA receptor subunits 354 
(downregulated); the DISC1 interactor Trio52, which modulates AMPA receptor currents in 355 
hippocampal CA1 pyramidal neurons53; vesicle proteins Exoc4, an exocyst component, and 356 
the SNARE STX7; and Gad2, a presynaptic protein that synthesises GABA in interneurons. 357 
These changes point to effects upon similar synaptic processes to those highlighted by 358 
RNASeq analysis. However, fewer changes were detected in the synaptosomes, probably 359 
due to the lower number of proteins identified in comparison with the RNASeq analysis, in 360 
which many relevant RNASeq changes were detected at the isoform level. 361 
 362 
Functional effects of the Der1 mutation upon synapses 363 
The RNAseq data point towards effects of the Der1 mutation upon synapses, which was 364 
confirmed by subsequent synaptic proteomics analysis. The observed changes include 365 
subtly altered expression of NMDA receptor isoforms and reduced AMPA receptor subunit 366 
levels. Moreover, we previously demonstrated that cultured hippocampal neuron dynamics 367 
and cell surface/synaptic expression of NMDA receptors are dysregulated by the Der1 368 
mutation12.  369 
 To examine these receptors functionally, whole cell patch-clamping was used to 370 
record currents from both receptor types in mature cultured hippocampal neurons (Figure 371 
2d). The AMPA:NMDA ratio is decreased in homozygous Der1 neurons indicating functional 372 
imbalance between these two receptor subtypes. This may be due in part to altered AMPA 373 
receptor currents, which although not statistically significant, are decreased in hetero- and 374 




receptors located at synapses in heterozygous Der1 hippocampus, and in cortex, will require 376 
future in-depth electrophysiological measurements. If it does indeed extend to synapses, the 377 
decreased AMPA:NMDA ratio could have many consequences including impaired triggering 378 
of NMDA receptor-dependent LTP, which is initiated by AMPA receptor-induced release of 379 
the magnesium block on NMDA receptors.  380 
 381 
Enrichment for dysregulation of putative schizophrenia, bipolar disorder and 382 
depression risk genes in heterozygous Der1 cortex and hippocampus 383 
A large number of putative schizophrenia risk genes have been identified from two large-384 
scale GWAS and one large-scale CNV study1-3. IPA maps many of these genes to shared 385 
molecular pathways. The top canonical pathway (Figure 3a) is ‘CREB signalling in neurons’. 386 
Others include ‘Synaptic long-term potentiation’ and ‘Synaptic long-term depression’, both 387 
mechanisms underlying synaptic plasticity. These findings largely agree with previous 388 
observations54. 389 
The heterozygous Der1 cortex combined RNASeq DESeq2 plus DEXSeq data were 390 
compared to the list of putative schizophrenia risk genes used above1, 2, but including only 391 
genes encoding synaptic proteins from the CNV study3 as defined by its authors. This 392 
identified significant enrichment for dysregulation of schizophrenia candidate gene 393 
orthologues (Table 2, Supplementary Table 2a, b). The top canonical pathways identified 394 
using this set of genes for IPA are ‘Synaptic long-term depression’, ‘CREB signalling in 395 
neurons’, ‘Synaptic long-term potentiation’ and ‘Calcium signalling’ (Figure 3a-c). These 396 
predictions are among the top five of those obtained using the full set of putative 397 
schizophrenia risk genes (Figure 3a), indicating that the Der1 mutation and genetic risk 398 
factors for schizophrenia converge upon the same pathways. 399 
Enrichment for dysregulation of schizophrenia candidate gene orthologues was also 400 
apparent using the heterozygous Der1 hippocampus combined RNAseq DESeq2 plus 401 
DEXSeq data (Table 2, Supplementary Table 2c, d), although there were too few genes to 402 




Large-scale genetic data are also available for bipolar disorder and depression4-6. 404 
IPA did not find that the genes identified from these studies converge strongly upon any 405 
canonical pathways, although a subset of depression-associated genes are involved in 406 
synaptic structure and activity6. Nonetheless, there is enrichment for dysregulation of the 407 
orthologues of candidate genes for both disorders in Der1 cortex, and for depression in Der1 408 
hippocampus (Table 2, Supplementary Table 2). Moreover, the dysregulated putative 409 
depression risk gene orthologues in Der1 cortex predict effects upon the ‘CREB signalling in 410 
neurons’ pathway (Figure 3a). 411 
We also examined overlaps between genes dysregulated in the Der1 mouse and two 412 
non-psychiatric illness related large-scale GWAS. For Alzheimer’s Disease55  there is 413 
enrichment for dysregulation of candidate gene orthologues in Der1 cortex (Table 2, 414 
Supplementary Table 2), with six of the nine gene matches (ABCA7, APOE, CLU, FERMT2, 415 
PTK2B/PYK2, SORL1) involved in Amyloid-Beta (A)-related processes56-61. This effect may 416 
be explained by observations that DISC1 interacts with Amyloid Precursor Protein62, and 417 
regulates A generation63, 64. The second comparison was to a study of cerebral cortex 418 
architecture65. Again, there is enrichment for dysregulation of candidate gene orthologues in 419 
Der1 cortex (Table 2, Supplementary Table 2), although no molecular pathways are 420 
highlighted. 421 
The enrichment for dysregulation of orthologues of candidate genes for brain 422 
disorders (which is particularly striking for schizophrenia) when combined with convergence 423 
upon specific molecular pathways already implicated in those disorders, indicates that the 424 
Der1 mutation may exert effects that are directly relevant to these human brain illnesses. 425 
 426 
Discussion 427 
Heterozygous Der1 mutant mice accurately recapitulate the effects of the t(1:11) 428 
translocation upon DISC1 expression in IPSC-derived neural precursors and cortical 429 




pathway predictions are similar between heterozygous Der1 cortex, and IPSC-derived 431 
cortical neuronal cultures from t(1:11) translocation carriers. Together these observations 432 
suggest that DISC1 disruption is an important factor in the increased risk of major mental 433 
illness displayed by t(1:11) translocation carriers, and argue that the Der1 mouse model can 434 
be used to study the neuronal effects of DISC1 disruption upon brain function to understand 435 
disease mechanisms in these individuals. 436 
 Many of the findings reported here are consistent with known DISC1 biology and 437 
brain function, but observations such as the lack of overt brain structural changes, and of 438 
increased density of hippocampal Parvalbumin-expressing interneurons were unexpected on 439 
the basis of previously described DISC1 mutant mice which model aspects of the effects of 440 
the t(1;11) translocation upon DISC1 expression35 (Supplementary Table 8). Such 441 
differences, and the many phenotypic differences between previously published mutants 442 
(Supplementary Table 8), accentuate the critical importance of studying a mutant that 443 
accurately mimics all effects of the t(1;11) translocation in order to understand disease 444 
mechanisms in t(1;11) translocation carriers. Other findings, such as the predicted 445 
dysregulation of astrocyte lipid metabolism, have not been reported previously. This is the 446 
first, and only, mutant mouse to accurately model effects of the t(1:11) translocation, and it 447 
therefore provides important and new insights into molecular mechanisms underlying the 448 
increased disease risk and psychiatric symptoms of t(1:11) translocation carriers. 449 
Structural and functional brain abnormalities have been reported in human t(1:11) 450 
translocation carriers11, whereas none were detected in the adult Der1 mice studied here. 451 
This difference may reflect fundamental species differences in brain structure and 452 
development, and/or secondary genetic or environmental factors consequent upon, or 453 
interacting with, the t(1:11) translocation event. Genetic effects may include loss of normal 454 
function of the additional disrupted genes DISC2 and DISC1FP113, 29, or an influence of 455 
genetic modifiers28. Environmental effects may include greater relative age, and duration of 456 




antipsychotic drugs. The latter progressively decreases grey matter volume in schizophrenia 458 
patients66, and decreases cortical volume in rats67.  459 
 The absence of brain structural changes, together with the lack of evidence for 460 
altered cell class proportions from RNASeq data deconvolution, indicates that the subtle 461 
transcriptomic and proteomic alterations identified in the Der1 mouse are principally due to 462 
altered cellular properties that are largely conserved between it and t(1:11) translocation 463 
carriers. EWCE analysis of RNASeq data suggests that the Der1 mutation may target 464 
distinct cell types including pyramidal neurons (CA1 and somatosensory) and interneurons. 465 
These findings correlate well with a previous EWCE analysis using large-scale 466 
schizophrenia GWAS data2, 34 which found that schizophrenia-associated SNPs map to 467 
genomic loci containing genes that are highly expressed in a limited number of brain cell 468 
types including CA1 and somatosensory pyramidal neurons, and interneurons34, thus 469 
implicating these cell types in the aetiology of schizophrenia. The additional cell types that 470 
appear to be targeted by the Der1 mutation: dopaminergic neurons, oxytocin/vasopressin-471 
expressing neurons and astrocytes/ependymocytes, were not implicated in schizophrenia by 472 
the genomic EWCE analysis. However, dopamine signalling is heavily implicated in 473 
schizophrenia, in part because all antipsychotic drugs in clinical use target the dopamine D2 474 
receptor68, while DRD2 is located at a genetic locus repeatedly found to associate with 475 
schizophrenia1, 2 and also with depression6. The neuropeptides oxytocin and vasopressin 476 
regulate many processes, including social behaviour and anxiety69, and are widely 477 
implicated in psychiatric disorders70. Astrocyte abnormalities have also been reported in 478 
relation to psychiatric disorders71. Thus, even if not directly targeted by genomic risk 479 
variants, these additional cell types do apparently contribute to psychiatric illness. 480 
Pyramidal neurons are the major excitatory neurons in the brain. Interneurons are 481 
inhibitory and regulate neuronal network excitability, primarily of pyramidal neurons. Our 482 
analyses suggest widespread targeting of pyramidal neurons and interneurons by the Der1 483 
mutation, thus excitation and inhibitory control of neuronal networks may be impaired. 484 




glutamate uptake by astrocytes is dysregulated. Our findings and predictions relating to 486 
pyramidal neurons, which are glutamatergic cells, and to astrocytic glutamate uptake, may 487 
be related to the decreased glutamate levels detected by brain imaging of t(1:11) 488 
translocation carriers9. Altered lipid production by astrocytes may be an additional factor 489 
affecting neuronal activity. Lipids are required for many processes, including synaptic 490 
activity47 and myelination48. We have previously demonstrated impaired myelination in Der1 491 
cortex which is presumably due, at least partially, to direct effects of the mutation upon 492 
oligodendrocytes because the corresponding IPSC-derived oligodendrocytes from t(1:11) 493 
translocation carriers are abnormal46. EWCE analysis did not, however, find evidence that 494 
oligodendrocytes are strongly targeted by the Der1 mutation, although some genes highly 495 
specific for this cell type are dysregulated, such as Myelin-Oligodendrocyte-Glycoprotein in 496 
cortex (Supplementary Table 2a), while genes that impact myelination are dysregulated in 497 
hippocampus (Supplementary Table 4b, 5). Altered lipid production by astrocytes could 498 
therefore be a contributory factor in the myelination phenotype.  499 
 Consistent with the targeting of cell types implicated in schizophrenia, the Der1 500 
mutation dysregulates orthologues of many genes implicated as risk factors for 501 
schizophrenia and depressive disorders through large-scale genome-wide association and 502 
CNV studies, as we have previously shown for the t(1:11) translocation in IPSC-derived 503 
neurons12. The pathways by which the t(1:11) translocation causes major mental illness may 504 
therefore overlap those targeted by common genetic risk factors for schizophrenia and 505 
depression. We speculate that disruption of the gene encoding the molecular scaffold 506 
DISC1, with knock-on effects for its numerous binding partners and functions can, at least 507 
partially, recapitulate the consequences of the more common scenario in psychiatric patients 508 
whereby multiple interacting common genetic risk factors are inherited, with both scenarios 509 
converging upon the same biological pathways. In agreement with this, the symptoms of 510 
t(1:11) translocation carriers are indistinguishable from the typical spectrum of clinical 511 




The convergence of the Der1 mutation with a subset of putative common genetic risk 513 
factors for schizophrenia and depressive disorders, and the convergence of this subset of 514 
genes upon synapses and synaptic plasticity6, 54  implies that, of all the Der1 cortex pathway 515 
predictions, dysregulated neurotransmission and synaptic plasticity are among the most 516 
critical factors in the psychiatric symptoms of t(1:11) translocation carriers. Notably, synaptic 517 
plasticity underpins cognition, which is characteristically impaired in schizophrenia. 518 
 Altogether, the EWCE and pathway analyses pointing to potential pyramidal 519 
neuron and interneuron dysfunction in hippocampus; the evidence that the number of 520 
apoptotic cells in CA1 may be increased; the higher density of hippocampal Parvalbumin-521 
positive interneurons; the extensive changes to synaptic protein expression in hippocampus 522 
synaptosomes; and the electrophysiology data indicating reduced AMPA:NMDA ratio in 523 
cultured hippocampal neurons, suggest that hippocampal circuits are especially sensitive to 524 
the mutation, although effects upon other brain regions are also likely. 525 
The hippocampus has multiple input/output pathways from/to other brain regions 526 
which are regulated by various neurotransmitters. Hippocampal dysfunction in Der1 mice 527 
could thus have numerous extrinsic/intrinsic causes, and knock-on effects. CA1 pyramidal 528 
neurons provide the major hippocampal output, including the hippocampal-to-PFC pathway 529 
that regulates NMDA receptor-dependent LTP and cognition72. This pathway is widely 530 
implicated in psychiatric disorders72. It is thus an exemplar of the mechanisms by which 531 
DISC1 disruption could confer susceptibility to major mental illness by bringing together the 532 
diverse effects described here, and elsewhere12, 46, in our studies of neural cells derived from 533 
t(1:11) translocation carriers, and of the corresponding Der1 mouse. Our findings thus 534 
provide important insights into potential disease mechanisms involving specific molecular 535 
pathways/functions and cell types in t(1:11) translocation carriers that are likely relevant to 536 
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Table 1 Top relevant altered cellular functions in heterozygous Der1 mouse cortex and 559 
human IPSC-derived neurons from members of the t(1:11) translocation family predicted 560 
using DESeq2+DEXSeq data. All Der1 mouse and human t(1;11) neuron functions are listed 561 
in Supplementary Table 4. 562 
Function 
(no. of moleculesa) 
Der1 cortex 
score 




(no. of genesb) 
Hypergeometric p value for 
enrichment 
(no. of shared genesc) 
General cell morphology    
Development of neurons (1,423) p=2e-53 (457) p=2e-13 (148) p=1e-3 (63) 
Morphogenesis of neurons (1,080) p=1e-47 (360) p=4e-13 (119) p=3e-4 (56) 
Morphology of neurons (1,123) p=7e-37 (303) p=1e-4 (80) p=6e-5 (37) 
Morphology of cells (4,370) p=1e-29 (902)   
Abnormal morphology of neurons (923) p=6e-25 (212)   
Cell contact    
Cell-cell contact (1,118) p=5e-26 (299) p=4e-6 (92) p=6e-4 (38) 
Development of gap junctions (327) p=1e-18 (123) p=2e-4 (37) p=0.08 (17) 
Formation of cell-cell contacts (414) p=6e-16 (138) p=8e-6 (48) p=0.08 (19) 
Formation of intercellular junctions (409) p=1e-15 (136) p=1e-5 (47) p=0.07 (19) 
Formation of plasma membrane (406) p=1e-15 (134) p=3e-6 (48) p=0.05 (20) 
Cytoskeleton    
Organization of cytoplasm (2,832) p=2e-64 (791) p=3e-16 (257) p=2e-6 (104) 
Organization of cytoskeleton (2,624) p=4e-57 (720) p=3e-16 (240) p=1e-8 (101) 
Microtubule dynamics (2,247) p=6e-54 (627) p=1e-14 (206) p=1e-6 (87) 
Development of cytoplasm (873) p=9e-19 (233) p=2e-4 (71) p=1e-5 (35) 
Formation of cytoskeleton (733) p=5e-14 (179)   
Cellular protrusions/neurites    
Neuritogenesis (1,067) p=2e-46 (354) p=4e-12 (115) p=2e-4 (55) 
Formation of cellular protrusions (1,645) p=1e-46 (488) p=3e-15 (170) p=2e-4 (70) 
Growth of neurites (910) p=5e-30 (261) p=1e-7 (81) p=6e-4 (36) 
Morphology of cellular protrusions (522) p=3e-25 (166)   
Morphology of neurites (414) p=6e-25 (139)   
Axons    
Axonogenesis (338) p=1e-18 (122) p=2e-7 (45) p=2e-3 (25) 
Morphology of axons (169) p=2e-16 (65)   
Growth of axons (281) p=2e-12 (87)   
Abnormal morphology of axons (133) p=4e-11 (46)   
Guidance of axons (202) p=5e-10 (71) p=2e-5 (29) ns (12) 
Dendrites    
Formation of dendrites (209) p=9e-19 (90)   
Dendritic growth/branching (446) p=8e-18 (131)   
Density of dendritic spines (143) p=1e-11 (49)   
Morphology of dendrites (138) p=3e-9 (49)   
Abnormal morphology of dendrites (75) p=3e-8 (32)   
Cell proliferation    
Proliferation of neuronal cells (1066) p=5e-28 (290) p=2e-9 (98) p=2e-3 (39) 
Neuronal migration    
Migration of neurons (362) p=1e-16 (125) p=8e-6 (43) p=0.03 (20) 
Circadian rhythm    
Circadian rhythm (132) p=3e-8 (55)   
Transport    
Organisation of organelle (948) p=1e-23 (270)   
Transport of vesicles (192) p=1e-14 (69)   
Endocytosis (924) p=8e-10 (202) p=3e-6 (76) p=2e-3 (27) 
Secretory pathway (367) p=8e-10 (93)   
Formation of vesicles (307) p=4e-9 (70)   
Neurotransmission    
Neurotransmission (716) p=5e-31 (233) p=5e-5 (62) p=0.03 (26) 
Potentiation of synapse (546) p=1e-28 (165)   
Long-term potentiation (539) p=4e-28 (163)   
Synaptic transmission (558) p=4e-27 (191) p=7e-06 (55) p=0.04 (24) 
Developmental process of synapse (303) p=2e-18 (117) p=1e-4 (36) p=0.08 (17) 
Excitatory postsynaptic potential (166) p=2e-15 (72)   
Long-term potentiation of brain (281) p=2e-13 (74)   




Long-term potentiation of cerebral cortex (254) p=6e-12 (66)   
Miniature excitatory postsynaptic currents (71) p=1e-11 (38)   
 563 
A full list of functions is provided in Supplementary Table 4a, d. Related functions are 564 
grouped, with top functions shown for each group. a, total number of molecules relating to 565 
each IPA function; b, number of dysregulated genes relating to each function; c, number of 566 
genes relating to function that are dysregulated in both Der1 cortex and human t(1:11) 567 
translocation neurons; italics, trend; ns, not significant 568 




Table 2 Enrichment for dysregulated expression of putative psychiatric illness risk gene 570 
orthologues in Der1 cortex and hippocampus.  571 












GWAS, schizophrenia1 108 348 121 genes at 61 loci p=1e-13 (p=8e-19) 6 genes at 6 loci p=0.04 (p=2e-4) 
GWAS, schizophrenia2 143 481 127 genes at 73 loci p=3e-6 (p=8e-19) 6 genes at 6 loci p=0.09 (p=8e-4) 
MAGMA, schizophrenia2  535 210 p=3e-30 15 p=2e-5 
CNV (synapse genes), 
schizophrenia3 
 52 25 p=8e-7 4 p=7e-4 
GWAS, depression4 44 70 19 at 19 loci p=0.02 (p=9e-5) 1 ns  
MAGMA, depression4  153 33 p=0.047 1 ns 
MAGMA meta-analysis, 
depression6 
 269 94 p=4e-11 6 p=0.01 
GWAS, bipolar disorder5 30 218 73 at 21 loci p=4e-8 (p=8e-10) 3 genes at 3 loci ns (p=2e-3) 
MAGMA, bipolar disorder5  152 49 p=2e-5 3 p=0.09 
GWAS, Alzheimer’s 
Disease55 
21 102 9 at 9 loci p=3e-3 (p=6e-3) 1 ns 
GWAS cerebral cortex 
architecture65 
 193 57 p=5e-5 1 ns 
 572 
Loci indicates the number of associated genomic loci identified by GWAS. Genes indicates 573 
the total number of genes at the associated loci, or the total number identified by MAGMA. 574 
Bracketed p values indicate enrichment for loci containing at least one dysregulated gene 575 
orthologue. italics, trend; ns, not significant 576 
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Legends to figures 877 
Fig. 1 The Der1 mutation targets specific cell types in heterozygous cortex and 878 
hippocampus. a Disc1 RNASeq reads normalised to total reads per sample in wild-type 879 
versus heterozygous Der1 cortex and hippocampus. b Heat maps of the top 500 880 
dysregulated genes identified by RNASeq of wild-type versus heterozygous Der1 cortex and 881 
hippocampus. c d EWCE analysis of heterozygous Der1 cortex and hippocampus, 882 
respectively, in mouse brain cell classes. asterisk, significance after Bonferroni correction; 883 
Emb, embryonic; Hyp, hypothalamic; SD, standard deviation e Parvalbumin expression in 884 
hippocampal sections from nine week old mouse brain. Enlarged regions showing 885 
Parvalbumin-expressing interneurons are indicated by boxes. scale bars, 100m f Average 886 
density of Parvalbumin-expressing interneurons. Hippocampus refers to the whole 887 
hippocampal formation. Data were analysed by Kruskal-Wallis one-way ANOVA, p=0.07 for 888 
the dentate gyrus; p=0.049 for the hippocampal formation. Horizontal line on graphs for each 889 
sample, average of values; WT, wild-type; HET, heterozygous Der1; HOM, homozygous 890 
Der1; DG, dentate gyrus; *, p<0.05 891 
 892 
Fig. 2 Consequences of the Der1 mutation. a Top relevant canonical pathway predictions for 893 
heterozygous Der1 cortex using whole gene, DESeq2, or whole gene and exon level, 894 
DESeq2+DEXSeq data. Asterisks indicate pathways highlighted in both cases. Where IPA 895 
predicts a direction of change this is indicated by a z score, with positive z scores indicating 896 
upregulation. b Altered gene expression in the ‘CREB signalling in neurons’ canonical 897 
pathway in heterozygous Der1 cortex, determined using whole gene and exon level 898 
DESeq2+DEXSeq data. To provide additional information, genes encoding calcium channels 899 
(CaCh), metabotropic glutamate receptors (mGLUR), ionotropic glutamate receptor subunits 900 
(iGLUR) and structural synaptic components have been added to the pathway using the IPA 901 
‘Build’ tool. Transcripts encoding components from the whole pathway are dysregulated at 902 
the whole gene and/or isoform level, including ionotropic AMPA and NMDA glutamate 903 




of which can control the calcium ion influx or G-protein activation that initiates the pathway. 905 
Genes encoding several synaptic scaffolds that are required to generate and maintain 906 
synapse structure/size and/or anchor glutamate receptors and calcium channels are also 907 
dysregulated, including Shank1, Homer1 and Dlg1/3/4, neurexins and neuroligins. Also 908 
dysregulated are genes encoding various factors downstream of glutamate receptors and 909 
calcium channels that activate the cAMP-dependent transcription factor CREB, such as 910 
various forms of Camk2, and adenylyl cyclases. The transcriptional machinery is additionally 911 
affected, including the cAMP-dependent transcription factor complex. Double outlines 912 
indicate protein complexes and classes, the components of which can be found in 913 
Supplementary Table 2a, b. Colour intensity represents strength of gene expression change, 914 
with graded colour within double outlined symbols representing overall direction of change 915 
within protein complexes. green, downregulated; red, upregulated; *genes identified by 916 
DEXSeq; ** genes identified by DEXSeq and DESeq2 c Sunburst plots showing SynGO 917 
annotated synaptic functions of the dysregulated proteins found in homozygous Der1 918 
hippocampus synaptosomes (FDR adjusted p-value < 0.05). Note that synaptosomes are 919 
enriched for the complete presynaptic terminal, the postsynaptic membrane and the 920 
postsynaptic density, as well as membranes originating from organelles such as the Golgi 921 
and endoplasmic reticulum73. d Quantification of AMPA and NMDA receptor currents by 922 
whole-cell patch clamping of neurons cultured from Der1 hippocampus. Data were analysed 923 
by one-way ANOVA, p=0.03. Horizontal line on graphs for each sample, average of values; 924 
WT, wild-type; HET, heterozygous Der1; HOM, homozygous Der1; *, p<0.05 925 
 926 
Fig. 3 The Der1 mutation dysregulates canonical pathways and genes related to 927 
schizophrenia and depression in heterozygous Der1 cortex. a Canonical pathway predictions 928 
for putative schizophrenia risk genes, and for orthologues of putative schizophrenia and 929 
depression risk genes that are dysregulated at the whole gene and exon level, as identified 930 
using DESeq2+DEXSeq data. b, c Altered schizophrenia risk gene orthologue expression in 931 




respectively. Double outlines indicate protein complexes and classes, the components of 933 
which can be found in Supplementary Table 2a, b. To provide additional information, genes 934 
encoding ionotropic glutamate receptor  subunits (Grid), AMPA receptor subunits (AMPAR), 935 
voltage-gated calcium channel subunits (VGCC), calcium channels (CaCh), ionotropic 936 
glutamate receptor subunits (iGLUR) and structural synaptic components have been added 937 
to the pathways using the IPA ‘Build’ tool. *genes identified by DEXSeq; red, dysregulated 938 
putative schizophrenia risk gene orthologue 939 




Functional brain defects in a mouse model of a chromosomal t(1;11) translocation 941 
that disrupts DISC1 and confers increased risk of psychiatric illness 942 
 943 
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Materials and methods 987 
Mouse colony maintenance 988 
Mice were housed in the Biomedical Research Facility at the University of Edinburgh. All 989 
mice were maintained in accordance with Home Office regulations, and all protocols were 990 
approved by the local ethics committee of the University of Edinburgh. Mouse genotyping 991 
was carried out as previously described1. 992 
 993 
Perfusion fixation and brain isolation 994 
Mice were anaesthetized with intraperitoneal injection of 0.1ml/10g Fentanyl/Fluanisone 995 
(Hypnorm®) and Midazolam (Hyponovel®). Deep anaesthesia was ensured by measuring 996 
withdrawal reflexes. The mice were then transcardially perfused with 4% paraformaldehyde 997 
at a rate of 0.2-0.5 ml/second. Brains were dissected out and the olfactory bulbs and 998 
cerebellum removed. Brains were transferred to 4% neutral buffered formalin for 24 hr, then 999 
stored in 70% ethanol. 1000 
 1001 
Magnetic resonance imaging 1002 
Brains were taken from twelve same-sex littermate genotype trios (one wild-type, one 1003 
heterozygote, one homozygote from the same litter, six male and six female trios). Brains 1004 
were removed from 70% ethanol and incubated for three weeks in 8mM gadolinium contrast 1005 
agent. Brains were then transferred to a 2ml Eppendorf tube filled with Fomblin and scanned 1006 
in pairs using a three-dimensional gradient echo pulse sequence and an Agilent 7T 1007 
DirectDrive MRI scanner, with acquisition parameters as follows; matrix 512x192x192 1008 
(reconstructed to 512x256x256); field of view 40x10x10 mm; repetition time/echo time 1009 
(TR/TE) 30/10 ms; 20 signal averages; total scan time 8.2 hours. A 26mm radiofrequency 1010 
coil was used for signal transmission and reception. Magnetic resonance images were 1011 
processed blind to genotype using a combination of FSL2, ANTs3 and in-house C++ software 1012 




head scans were bias-field corrected6 before being split into individual sample images. 1014 
Registration was then performed between each subject and the Dorr atlas image7 to ensure 1015 
all samples were aligned. An average study template image was then constructed using MR 1016 
images from all animals8. The resulting template was then non-linearly registered to the atlas 1017 
image. All subject images were then non-linearly registered to the study template. The 1018 
inverse transforms from the atlas to the study template and from the study template to each 1019 
subject were applied to calculate the total brain volume and individual brain region of interest 1020 
(ROI) volumes of each subject. ROIs match those found in the Dorr atlas7. 1021 
 1022 
Histology 1023 
Five 9 week old male littermate genotype trios were used for histological analysis except 1024 
where indicated below. Perfused brains were removed from 70% ethanol and paraffin wax-1025 
embedded, then sections were cut from three different zones of the brain; Bregma ≈2.46 1026 
(prefrontal cortex); Bregma ≈ 0.75 (lateral ventricles and corpus callosum); Bregma ≈ -1.94 1027 
(hippocampus). Brains were processed by the University of Edinburgh Shared University 1028 
Research Facilities (SURF), using a Leica RM2235 base sledge microtome. Twenty coronal 1029 
sections of 10μm were cut for each block. Sections were mounted on to Superfrost Plus 1030 
slides (ThermoFisher Scientific) and oven-dried. Two successive sections were used per 1031 
location for each procedure. 1032 
To visualize cytoarchitecture by Nissl staining, sections were dewaxed in xylene, 1033 
then rehydrated through graded alcohols. Rehydrated slides were incubated for 2 minutes in 1034 
0.2 % Cresyl fast violet solution containing 10 drops of acetic acid per 100 ml. Sections were 1035 
dehydrated through graded alcohols, then cleared in xylene and cover-slipped with the 1036 
xylene-based mounting solution DPX (Fisher Scientific). 1037 
To examine Parvalbumin-expressing neurons, sections were dewaxed and 1038 
endogenous peroxidase activity quenched by incubating in methanol containing 1% 1039 




at room temperature, then microwaved for 20 minutes at high power. Sections were cooled 1041 
on ice for 20 minutes, then blocked using 20% normal goat serum (Vector) for 1 hour. 1042 
Sections were next incubated overnight at 4°C with mouse anti-Parvalbumin primary 1043 
antibody (Sigma-Aldrich P3088, 1:400 dilution), followed by incubation at room temperature 1044 
for one hour with biotinylated goat anti-mouse secondary antibody (Sigma-Aldrich, 1:200 1045 
dilution). Next, sections were incubated in Vectastain Elite Avidin-Biotin Complex (Vector 1046 
Laboratories) for 30 minutes before visualization by incubation with 0.05% 3,3’-1047 
diaminobenzidine tetrahydrochloride (DAB, Sigma-Aldrich) containing 0.001% hydrogen 1048 
peroxide. Finally, sections were dehydrated through graded alcohol, cleared in xylene, and 1049 
cover slipped with DPX. To analyse the distribution of interneurons, the prefrontal cortex 1050 
sections were initially separated into different regions of interest, distinguished using 1051 
anatomical features and the Mouse Brain Atlas in stereotaxic coordinates9, then combined. 1052 
In the hippocampal sections interneurons were counted in CA1 and the dentate gyrus, as 1053 
well as the whole hippocampal area. ROIs were set at the same position on each section and 1054 
the cells were counted manually, blind to genotype, using the Fiji ‘Cell Counter’ plugin. 1055 
To examine apoptotic cells, the same procedure was used except the primary 1056 
antibody was specific for active (cleaved) caspase-3 (Sigma-Aldrich, AB3623, 1:70 dilution), 1057 
the secondary antibody was biotinylated goat anti-rabbit (Sigma-Aldrich, 1:200 dilution), with 1058 
nickel was added to the DAB solution. Sections were counterstained with Nuclear Fast Red 1059 
(Vector Laboratories). 1060 
For cortical layer measurements in barrel cortex, brains were taken from three to five 1061 
month old mice and immediately placed in 4% paraformaldehyde overnight. Fixed brains 1062 
were sectioned using a cryostat (Leica) coronally at 50µm from rostral to caudal. Sections 1063 
were mounted onto Superfrost slides (VWR) in gelatin solution. The slices were washed in 1064 
acetone and water, then stained in 1% thionin-Nissl and dehydrated in increasing 1065 
concentrations of alcohol, cleared in xylene and then coverslipped using DPX (Fluka). 1066 
 1067 




For most purposes, images of brain sections were captured using a dotSlide scanner 1069 
(Olympus). Equivalent areas of both hemispheres were quantified on each slide, blind to 1070 
genotype, then averaged per animal. Cell density was determined within the regions of 1071 
interest shown (Supplementary Figure 2), which were manually drawn and set using the Fiji 1072 
region of interest manager, with area determined and cells counted using the Fiji ‘Cell 1073 
Counter’ plugin. 1074 
 For cortical layer measurements in barrel cortex, brain sections were imaged using a 1075 
light microscope (Olympus). Barrel cortex could be identified by the presence of barrels in 1076 
layer IV cortex (Bregma anterior-posterior 0.38 to -1.94mm) whilst sections of brain 1077 
containing prefrontal cortex (Bregma 2.80 to 2.10mm) were identified using a mouse brain 1078 
atlas9. Analysis of cortical thickness was performed within distinct brain areas. For cortical 1079 
layer thickness, layers I, II/III, IV and V/IV were measured as distances perpendicular to the 1080 
pial surface in addition to the total cortical thickness in barrel cortex. Total cortical thickness 1081 
between the central sulcus and white matter for limbic cortex was measured for prefrontal 1082 
cortex using Camera Lucida (Olympus). 1083 
 1084 
RNA sequencing 1085 
Hippocampi, and cortices minus hippocampus, cerebellum and olfactory bulbs, were 1086 
dissected from the right brain hemisphere mice at nine weeks of age. Samples were snap 1087 
frozen in liquid nitrogen and stored at -80oC, then processed in batches of mixed genotypes 1088 
to extract the RNA. Total RNA samples were assessed with a Fragment Analyser (Agilent) 1089 
for quality and integrity of total RNA. Libraries were prepared using 100ng of each total RNA 1090 
sample using the TruSeq Stranded mRNA Library Prep Kit (Illumina). Single end RNA 1091 
Sequencing was carried out to a depth of approximately 60 to more than 100 million reads. 1092 
Demultiplexing of sequencing reads was carried out using CASAVA (version 1.8.2, Illumina), 1093 
with adapters trimmed using Skewer (version 0.1.116)10. Raw sequence reads were mapped 1094 




Raw counts at gene level were obtained using htseq-count12 (version 0.7.2, in the 1096 
default union mode) on the alignment bam files and the Ensembl release 85 mouse gtf file. 1097 
Differential gene expression was analysed using DESeq2 from the R statistical 1098 
package13. Differential exon expression was analysed using DEXSeq14 (version 1099 
1.19.4) using exon counts obtained by running the script “dexseq_count.py” provided 1100 
by the Deseq package. Adjusted-p-values were calculated via a Benjamini-Hochberg 1101 
Procedure to get False Discovery Rate (FDR), the default in Deseq2 package. Raw 1102 
count data for all samples were together subjected to a regularised logarithm 1103 
transformation10 using the DESeq2 package version 1.16.1. For each heat map, the 1104 
transformed counts for each gene were normalised to Z-scores across all samples. 1105 
Heat maps of gene expression were generated using R (version 3.4.2) and RStudio 1106 
(version 1.0.143). 1107 
 1108 
Expression-weighted cell-type enrichment (EWCE) analysis 1109 
This analysis used the Karolinska Institute ‘Superset’ of RNASeq profiles generated from six 1110 
independent single cell RNASeq studies of several brain regions and cell types. The 1111 
Superset consists of 24 cellular classes generated by hierarchical clustering of nearly 9,970 1112 
mouse brain single cell RNASeq profiles (all generated by exactly the same method) 1113 
followed by cell type identity assignment15. Profiles consist of a set of specificity values 1114 
which provide a measure of gene expression enrichment (calculated from mean expression 1115 
of each gene in a cellular class divided by its mean expression in all cellular classes) for 1116 
each gene detected in that class15. Some cells were isolated from mouse cortex, 1117 
hippocampus, striatum, hypothalamus and midbrain, while others were the result of 1118 
specifically isolating cortical Parvalbumin-positive interneurons or oligodendrocytes from 1119 
multiple brain regions including somatosensory cortex and hippocampus. The ages of the 1120 
mice used to generate the profiles include embryonic and a range from P14 to P90. Each 1121 




types, not all necessarily from the same brain region or age. Superset profiles were 1123 
downloaded from http://hjerling-leffler-lab.org/data/scz_singlecell using specificity table: 1124 
ctd[[1]]$specificity and expression table: ctd[[1]]$mean_exp. Analysis was carried out in the 1125 
R package using script downloaded from https://github.com/NathanSkene/EWCE/ (version 1126 
0.99.2), and default options with Bonferroni multiple testing correction. The full list of 1127 
expressed Der1 cortex or hippocampus genes was used as background, as appropriate. The 1128 
script was run with 10,000 repetitions. The Superset samples were sequenced at a lower 1129 
depth than the Der1 samples, and using unique molecular identifiers. Consequently only the 1130 
most abundantly expressed genes (up to 14,581) were detected. For cortex, 1,794 of 2,125 1131 
dysregulated genes are present in the Superset profiles. For hippocampus, 151 of 175 1132 
dysregulated genes are present in the Superset profiles. Der1 whole gene DESeq2 RNASeq 1133 
data were used for this analysis. 1134 
 1135 
RNASeq deconvolution 1136 
RNASeq deconvolution was carried out using the cell Karolinska Institute ‘Superset’ of 1137 
RNASeq profiles15 described above under EWCE analysis as reference. Specificity value 1138 
thresholds of 0.75 and 0.6 were set to ensure that the most highly enriched genes were used 1139 
in this analysis, thus profile signatures consisted of genes with at least one specificity value 1140 
in one cell type above these thresholds. To provide context, specificity value=1 represents 1141 
100% specificity for one cell class, the astrocyte marker Gfap exhibits a specificity value of 1142 
0.87 in the astrocyte/ependymocyte class, the oligodendrocyte marker Mbp exhibits a 1143 
specificity value of 0.6 in the oligodendrocyte class, the interneuron marker Parvalbumin 1144 
exhibits specificity values of 0.41 and 0.27 in the interneuron and striatal interneuron 1145 
classes, respectively, and the synapse marker Dlg4 (Psd95) exhibits specificity values of 1146 
~0.1 in pyramidal neurons and <0.1 in other neuron classes15. This resulted in the use of 346 1147 
genes for threshold=0.75, and 752 genes for threshold=0.6, of which 285 and 653 are 1148 




 Deconvolution was carried out using CIBERSORT Jar Version 1.06 (May 5th 2017)16, 1150 
available at the web interface https://cibersort.stanford.edu. The ability of CIBERSORT to 1151 
accurately deconvolute the 24 cell types in the Superset was examined by creating artificial 1152 
cell mixes by combining Superset gene expression values in various proportions from 0 to 1153 
0.5. CIBERSORT input was then compared to output to determine the efficiency of artificial 1154 
sample deconvolution for the 24 cell types. 1155 
 1156 
Pathway analysis 1157 
DESeq2 data were examined separately or combined with DEXSeq data by Ingenuity 1158 
Pathway Analysis (IPA, Qiagen), using corrected p values and log2 fold changes, and the 1159 
corresponding full list of expressed genes for each brain region as the background gene set. 1160 
Human t(1;11) translocation neuron RNASeq data1 were similarly analysed using IPA. 1161 
Pathway analysis of putative schizophrenia or depression risk genes was carried out using 1162 
IPA and the full cortical gene expression list as the background gene set. Pathway analysis 1163 
of dysregulated orthologues of putative schizophrenia or depression risk genes used the 1164 
corresponding full list of expressed genes for each brain region as the background set. 1165 
Adjusted p<0.05, and z>2 or z<-2 were used as thresholds throughout. Pathway analysis of 1166 
dysregulated genes from cell class profiles used the full Superset profile as background. A 1167 
specificity value threshold of 0.2 was set to ensure that a sufficient number of the most 1168 
specific genes were used in the analysis. For context regarding specificity values see 1169 
deconvolution, above. Where DEXSeq identified dysregulated sequences that did not 1170 
unambiguously map to a single gene, or mass spectrometry identified peptides that could 1171 
not be unambiguously mapped to a single protein (due to close homology with other 1172 
proteins), all possible genes and proteins were included in the pathway analysis. 1173 
 1174 
Synaptosome preparation and mass spectrometry 1175 
Synaptosomes were prepared from 8-10 week old Der1 cortex and hippocampus (six wild-1176 




homogenized in HEPES buffer (5 mM HEPES, pH 7.4, 0.32 M sucrose supplemented with 1178 
protease inhibitor cocktail, Roche) and centrifuged at 1000 x g for 10 min at 4°C. The 1179 
supernatant was subsequently centrifuged in a 0.85/1.2 M sucrose gradient at 100,000 x g 1180 
for 2 hours. Synaptosomes were recovered from the 0.85/1.2 M sucrose interface and 1181 
concentrated by centrifugation at 18.000 x g for 30 min. 1182 
 Samples were digested using filter aided sample preparation (FASP) with some 1183 
modifications18. Briefly, 20 μg of each protein sample were incubated with 75 μL 2% SDS, 1 1184 
mM Tris(2-carboxyethyl)phosphine at 55°C for 1 hour, after which samples were incubated 1185 
with 0.5 μL 200 mM methyl methanethiosulfonate for 15 min. Next, 200 μL 8 M Urea in Tris 1186 
pH 8.8 were added and the samples were transferred to Microcon-30 filter tubes (Millipore). 1187 
Samples were washed 4 times with 8M Urea in Tris buffer and 4 times with 50 mM 1188 
ammonium bicarbonate by centrifugation at 14,000 x g for 10 min each. Proteins were 1189 
digested with 0.7 μg Trypsin/Lys-C Mix (MS grade, Promega) overnight at 37°C. Peptides 1190 
were eluted with 200 μL 50 mM ammonium bicarbonate, dried in SpeedVac and stored at -1191 
20°C. 1192 
Peptides were analysed by micro LC MS/MS using an Ultimate 3000 LC system 1193 
(Dionex, Thermo Scientific) and the TripleTOF 5600 mass spectrometer (Sciex). Peptides 1194 
were trapped on a 5 mm Pepmap 100 C18 column (300μm i.d., 5μmparticle size, Dionex) 1195 
and fractionated on a 200 mm AlltimaC18 column (300μm i.d., 3μm particle size). The 1196 
concentration of acetonitrile in the mobile phase was increased at a flow rate of 5μL/min 1197 
from 5 to 18% in 88 min, to 25% at 98 min, 40% at 108 min and to 90% in 2 min. Peptides 1198 
were electro-sprayed into the mass spectrometer with a micro-spray needle (at 5500 V). The 1199 
mass spectrometer was operated in a data-independent mode, as described in19. Each cycle 1200 
consisted of a parent ion scan of 150 msec and 8 Da MS/MS windows (80 msec scan time 1201 
each), throughout a 450-770 m/z mass range. The collision energy for each window was 1202 
calculated for a 2+ ion centered upon the window (spread of 15 eV). 1203 
The data were analysed with Spectronaut Pulsar v 12.0.20491.21.2810920 and using 1204 




samples containing spike-in iRT peptides (Biognosys). Cross-run normalization was enabled 1206 
using local normalization strategy. Only peptides quantified with a Q-value ≤ 10-2 and 10-3 1207 
(for hippocampus and cortex datasets, respectively) across all samples in at least two 1208 
groups were considered. Limma R package was used to Loess normalize protein abundance 1209 
(‘normalizeCyclicLoess’ function, ‘fast’ method and 10 iterations). Volcano plots were 1210 
generated using R (version 3.6.2). Protein were annotated to synaptic genes and sunburst 1211 
plots were generated using SynGO 1.0 database and online tool21. 1212 
 1213 
Hippocampal Cell Culture and Electrophysiological recordings 1214 
Primary hippocampal cultures were prepared from individual E17.5 DER littermate pups as 1215 
described22.  Briefly, hippocampi were dissected from pups, incubated in Papain, dissociated 1216 
and grown in Neurobasal A growth medium containing 1% Rat Serum and supplemented 1217 
with B-27, and maintained until Days In Vitro (DIV) 21. 1218 
Whole cell patch clamp recordings were performed as described23.  Briefly, 1219 
coverslips containing DIV 21 hippocampal neurons were transferred to a recording chamber 1220 
with a constant (3-5ml/min) perfusion of external recording solution containing: 150 mM 1221 
NaCl, 2.8 mM KCl, 10 mM HEPES, 2 mM CaCl2, 10 mM D-glucose and 100 µM glycine, pH 1222 
7.35, 320 mOsm. Tetrodotoxin citrate (300 nM) was included to block action-potential driven 1223 
excitatory events.  Patch-pipettes were pulled from borosilicate glass (Harvard Apparatus, 1224 
Kent, UK) with a resistance of 3-5 MΩ, and filled with a K-gluconate-based internal solution 1225 
containing: 141 mM Potassium Gluconate, 2.5 mM NaCl, 10 mM HEPES, 11 mM EGTA, pH 1226 
7.35).  Currents were evoked by S-AMPA (50 µM) and NMDA (150 µM). All currents were 1227 
recorded at room temperature, using an axopatch 200B amplifier (Molecular Devices, Union 1228 
City, CA).  Neurons were voltage-clamped at -60 mV.  Whole-cell currents were analysed 1229 
using WinEDR v3.2 software (John Dempster, University of Strathclyde, UK), with currents 1230 
normalised to cell capacitance.  For statistical analysis, n was taken as the number of pups, 1231 
with n=3 WT, 4 HET and 3 HOM.  A total of 12 WT, 14 HET and 11 HOM genotype 1232 





Statistical analysis 1235 
For analysis of MRI data, a multivariate general linear model 2-way MANCOVA statistical 1236 
test was performed using SPSS statistics 22 (IBM) to determine group-level differences in 1237 
brain ROI volumes with genotype as fixed effect, total brain volume and brain region as 1238 
dependent variable, and littermate trio groupings as covariate. 1239 
For enrichment analysis, hypergeometric probabilities were calculated using 1240 
keisan.casio.com/exec/system/1180573201. As with the pathway analysis, where DEXSeq 1241 
identified dysregulated sequences that did not unambiguously map to a single gene, or mass 1242 
spectrometry identified peptides that could not be unambiguously mapped to a single protein 1243 
(due to close homology with other proteins), all possible genes and proteins were included in 1244 
the enrichment analysis. 1245 
For the proteomic analysis, empirical Bayes moderated t-statistics with multiple 1246 
testing correction by false discovery rate were performed on log-transformed protein 1247 
abundances (‘eBayes’ and ‘topTable’ functions from Limma R package), as previously 1248 
described18, 19, 24, 25. Proteins with a FDR adjusted p-value < 0.05 were considered 1249 
significantly regulated for subsequent downstream analysis. 1250 
 Other statistical analyses were carried out using GraphPad Prism, with statistical 1251 
tests used stated in figure legends. 1252 
 1253 
Supplementary Table 1 (Excel file) Magnetic resonance imaging data. Both hemispheres, 1254 
regional volumes (mm3) corrected to individual whole brain volumes, left and right 1255 
hemispheres combined, separate hemispheres, regional volumes (mm3) corrected to 1256 
individual whole brain volumes, left and right hemispheres considered separately 1257 
 1258 
Supplementary Table 2 (Excel file) RNA sequencing data. a DeSeq2 (whole gene 1259 




cortex data, c DeSeq2 (whole gene differential expression) Der1 hippocampus data, d 1261 
DEXSeq (exon level differential expression) Der1 hippocampus data. In each case data are 1262 
provided with comparisons to human IPSC-derived cortical neuron cultures from members of 1263 
the t(1;11) family12, two large-scale genome-wide association studies of schizophrenia1, 2, 1264 
synapse genes from a large-scale schizophrenia CNV study3, two large-scale genome-wide 1265 
association studies of depression4, 6, a large-scale genome-wide association study of bipolar 1266 
disorder5, a large-scale genome-wide association study of Alzheimer's Disease55 where 1267 
matches were found, and a large-scale genome-wide association study of cerebral cortex 1268 
architecture65, where matches were found (references numbered according to main text). 1269 
Overlaps are represented by a gene name in the relevant genetic study column. Non-1270 
overlaps are represented by empty cells, BaseMean, mean of normalised counts of all 1271 
samples; p value, p value for wild-type versus heterozygous; adjusted p value, p value 1272 
adjusted for multiple testing 1273 
 1274 
Supplementary Table 3 (Excel file) Dysregulated genes with conserved cAMP response 1275 
elements according to http://natural.salk.edu/creb/. 1276 
 1277 
Supplementary Table 4 (Excel file) Ingenuity Pathway Analysis functions. a functions 1278 
enriched for dysregulated genes in Der1 cortex. All functions in the categories 'Molecular 1279 
and cellular function' and 'Physiological system development and function' are included. 1280 
Selected top relevant functions are provided in Table 1. Data are provided with comparisons 1281 
to functions predicted from human IPSC-derived cortical neuron cultures from members of 1282 
the t(1;11) family12 (reference numbered according to main text). Overlaps are represented 1283 
by an x in the human neuron column. Non-overlaps are represented by empty cells, b, 1284 
functions enriched for dysregulated genes in Der1 hippocampus. All functions in the 1285 
categories 'Molecular and cellular function' and 'Physiological system development and 1286 




5. c, functions enriched for dysregulated genes in Superset cell classes. All functions in the 1288 
categories 'Molecular and cellular function' and 'Physiological system development and 1289 
function' are included. Selected top relevant functions are provided in Supplementary Table 1290 
6. d, functions enriched for dysregulated genes in human IPSC-derived cortical neuron 1291 
cultures from members of the t(1;11) family. All functions in the categories 'Molecular and 1292 
cellular function' and 'Physiological system development and function' are included. Selected 1293 
top relevant functions are provided in Table 1. The genes listed for each function are 1294 
dysregulated in the corresponding dataset. 1295 




Supplementary Table 5 Top predicted relevant altered functions in heterozygous Der1 1297 
mouse hippocampus.  1298 
Function (no. of moleculesa) Der1 hippocampus score (no. of genesb) 
General cell morphology  
Development of neurons (1,423) p=2e-9 (33) 
Morphology of neurons (1,123) p=8e-7 (22) 
Maturation of neurons (114) p=8e-6 (7) 
Abnormal morphology of neurons (923) p=3e-5 (16) 
Differentiation of neurons (648) p=5e-4 (14) 
Cell contact  
Adhesion of neuronal cells (89) p=8e-9 (9) 
Formation of plasma membrane (406) p=1e-8 (17) 
Cell-cell contact (1,118) p=1e-5 (22) 
Cell-cell contact of neurons (24) p=1e-5 (4) 
Cell-cell adhesion of neurons (22) p=3e-4 (3) 
Cytoskeleton  
Microtubule dynamics (2,247) p=2e-4 (31) 
Organization of cytoskeleton (2,624) p=7e-4 (33) 
Cellular protrusions/neurites  
Neuritogenesis (1,067) p=2e-6 (23) 
Formation of cellular protrusions (1,645) p=1e-4 (26) 
Growth of neurites (910) p=2e-4 (16) 
Branching of cells (746) p=2e-4 (14) 
Extension of neurites (267) p=5e-4 (8) 
Axons  
Extension of axons (134) p=5e-3 (5) 
Myelination of optic nerve (8) p=2e-3 (2) 
Myelination (8) p=5e-3 (7) 
Dendrites  
Formation of dendrites (209) p=2e-4 (8) 
Dendritic growth/branching (446) p=4e-4 (10) 
Density of dendritic spines (143) p=1e-3 (5) 
Morphology of dendrites (138) p=3e-3 (5) 
Length of dendrites (47) p=3e-3 (3) 
Cell proliferation  
Proliferation of epithelial cells (996) p=3e-3 (14) 
Neurogenesis of cerebral cortex (69) p=5e-3 (3) 
Proliferation of stem cells (372) p=8e-3 (7) 
Transport  
Exocytosis (336) p=9e-4 (8) 
Transport of dopamine (76) p=8e-4 (3) 
Secretion of neurotransmitter (248) p=1e-3 (7) 
Release of neurotransmitter (510) p=1e-3 (7) 
Transport of 5-hydroxytryptamine (40) p=2e-3 (2) 
Neurotransmission  
Developmental process of synapse (303) p=3e-9 (16) 
Neurotransmission (716) p=8e-8 (20) 
Synaptic transmission (558) p=3e-7 (17) 
Maturation of synapse (36) p=3e-5 (4) 
Miniature excitatory postsynaptic currents (71) p=2e-4 (5) 
Plasticity of synapse (170) p=3e-4 (7) 
Excitatory postsynaptic potential (166) P=3e-4 (7) 
Paired-pulse facilitation of synapse (55) p=9e-4 (4) 
Action potential of cells (238) p=1e-3 (7) 
Formation of excitatory synapses (14) p=3e-3 (2) 
 1299 
A full list of functions is provided in Supplementary Table 4b. Related functions are grouped, 1300 
with top functions shown for each group. a, total number of molecules relating to each IPA 1301 
function; b, number of dysregulated genes relating to each function 1302 




Supplementary Table 6 Top predicted relevant altered cellular functions in cell classes from 1304 
EWCE analysis.  1305 
Superset cell class  
Function 
(no. of moleculesa) 
Der1 cortex score 
(no. of genesb) 
Der1 cortex pyramidal CA1  
Long-term potentiation (539) p=6e-6 (8) 
Neurotransmission (773) p=5e-5 (9) 
Excitation of cerebral cortex cells (46) p=6e-5 (3) 
Synaptic transmission (601) p=6e-5 (8) 
Excitation of neurons (167) p=9e-5 (4) 
Remodelling of F-actin structure (7) p=1e-4 (2) 
Development of neurons (1,474) p=2e-4 (12) 
Neuritogenesis (1,110) p=3e-4 (10) 
AMPA mediated synaptic current (9) p=3e-4 (2) 
Activation of neurons (252) p=3e-4 (4) 
  
Der1 cortex pyramidal somatosensory  
Efflux of dopamine (63) p=2e-5 (3) 
Quantity of dense core vesicles p=2e-4 (2) 
Neurotransmission (773) p=3e-4 (9) 
Synaptic transmission 601) p=3e-4 (8) 
Exocytosis by eukaryotic cells (99) p=1e-3 (3) 
Fusion of synaptic vesicles (21) p=1e-3 (2) 
Action potential of neurons (198) p=3e-3 (4) 
Quantity of synapse (92) p=3e-3 (3) 
Accumulation of cortical actin filaments (1) p=4e-3 (1) 
Activation of parvocellular neurons (1) p=4e-3 (1) 
  
Der1 cortex interneurons  
Neurotransmission (773) p=7e-6 (7) 
Activation of neurons (252) p=1e-5 (4) 
Action potential of neurons (198) p=5e-5 (4) 
Excitation of neurons (167) p=2e-4 (3) 
GABA-mediated receptor currents (14) p=2e-4 (2) 
Fusion of plasma membrane (34) p=4e-4 (2) 
Excitation of cerebral cortex cells (46) p=5e-4 (2) 
Activation of enzyme (584) p=9e-4 (5) 
Accumulation of 2-arachidonoylglycerol (3) p=1e-3 (1) 
Activation of parvocellular neurons (1) p=1e-3 (1) 
  
Der1 cortex astrocytes/ependymocytes  
Fatty acid metabolism (1,492) p=3e-8 (17) 
Concentration of lipid (2,135) p=3e-7 (19) 
Uptake of amino acids (264) p=8e-7 (6) 
Uptake of glutamine family amino acid (133) p=9e-7 (5) 
Function of neuroglia (56) p=2e-6 (5) 
Mass of fat (24) p=2e-6 (4) 
Transport of amino acids (394) p=3e-6 (7) 
Concentration of fatty acid (721) p=4e-6 (10) 
Function of central nervous system (152) p=4e-6 (6) 
Function of oligodendrocytes (9) p=5e-6 (3) 
 1306 
A full list of functions is provided in Supplementary Table 5c, e. The most highly enriched 1307 
genes that are dysregulated in Der1 cortex for each cell class were used for IPA analysis, 1308 
with specificity value cut-off=0.2 (SV=1 indicates 100% specificity, see methods for more 1309 




insufficient for meaningful pathway analysis. a, total number of molecules relating to each 1311 
IPA function; b, number of dysregulated genes relating to each function  1312 
 1313 
Supplementary Table 7 (Excel file) Synaptosome mass spectrometry data. a, Mass 1314 
spectrometry analysis of cortex synaptosomes isolated from wild-type (WT), heterozygous 1315 
(HET) or homozygous (HOM) Der1 mice, b, Mass spectrometry analysis of hippocampus 1316 
synaptosomes isolated from wild-type (WT), heterozygous (HET) or homozygous (HOM) 1317 




Supplementary table 8 Comparison between characteristics of the Der1 mouse and 1319 
pertinent characteristics of mutant mice that are known or proposed to be relevant to the 1320 
t(1;11) translocation. 1321 





















distribution indicative of 
an increased density of 
weaker synapses1 
 
altered expression of 
genes involved in 
synapse formation, 
structure & function 
 
altered expression of 
genes critical for 
synaptic plasticity and 
long-term potentiation, 
including the CREB 
signalling pathway 
 




↑ NMDA receptor 
motility1 
 
altered expression of 
genes required for 







Disc1 gene replaced 
with human DISC1-
Boymaw or Boymaw-
DISC1 cDNA fusion 
transgenes (Boymaw 
is otherwise known 
as DISC1FP1) 
resulting in Disc1 
promoter-driven 
forced expression of 
putative chimeric 
proteins28 (whose 
expression in t(1;11) 
carriers remains to 
be established1) 
 
 ↓ cortical expression of 
NMDA receptor subunit 




deletion of exons 2 & 
3 from endogenous 
mouse Disc1 gene, 
abolishes full-length 
Disc1 expression 
↓ density of 
Parvalbumin-positive 
interneurons in many 
cortical areas30, and in 
hippocampus31 
 








release & ↑ dopamine 
receptor expression in 
nucleus accumbens31 




↓ dendritic ITPR1 








deletion of exons 1-3 
from endogenous 
mouse Disc1 gene, 
abolishes full-length 
Disc1 expression 










(encoded by exons 





↓ NMDA receptor 
GluN2A & GluN2B, ↑ 
GluN1 (trend) protein 
expression in 
hippocampus38 
↑ long-term potentiation 
in Schaffer collateral 




















↑ lateral ventricle 
volume 
 
↓ cerebral cortex 
thickness 






connectivity & reduced 
neurotransmitter 













inducible control of 
CaMKII promoter 










↓ cortical dopamine41 & 
dopamine D2 receptor 
binding in olfactory 
tubercle and nucleus 
accumbens (trend)44 
 
↑ dendritic spine 
density41 
 




↑ NMDA receptor 




altered homeostasis of 
dopamine and 




reduced capacity of 
astrocytes to support 





currents in cultured 
cortical neurons48 
altered expression of 








control of CamKII 
promoter 
 




↑ lateral ventricle 
volume50 
 






regulation, in fast 
spiking parvalbumin-










control of PrP 
promoter 
 
no gross structural 
changes53 





(exon 1-8) transgene 
inducibly expressed 
in neural precursor 
cells 
 





cortex, and motor 
cortex54 









↓ dendritic spine 
density & altered spine 




















termination signal in 
intron 8, abolishes 
full-length Disc1 
expression and may 
express C-terminally 
truncated protein 
due to the 
termination codon 
within exon 7 








plasticity at mossy 
fibre-CA3 circuit58 
 




↑ short-term depression 
& probable ↑ 
neurotransmitter 




















The mutants fall into three main categories 1) recapitulation of the gene fusion between 1323 
DISC1 and DISCFP1 (Der1, transgenic Boymaw fusions), 2) elimination of full-length Disc1 1324 
expression (Der1, transgenic Boymaw fusions, Disc1△2-3, DISC1-LI, Disc1Tm1Kara), 3) 1325 
transgenic overexpression of a truncated form of Disc1 or DISC1 encoded by exons 1-8 that 1326 
was inferred to arise from the t(1;11) prior to discovery of the DISC1/DISCFP1 gene fusion 1327 








Supplementary Fig. 1 Flowchart indicating the experimental approach taken. Superscript 1330 
numbers indicate references according to the main (not supplementary) text. 1331 








Supplementary Fig. 2 Regions of interest for image analysis of cell density, Parvalbumin 1337 
and cleaved Caspase 3. a Hippocampus (HP). The box indicates the region of the Stratum, 1338 
Radiatum, Lacunosum and Moleculare (SRLM) in which cell density was quantified. Dotted 1339 
lines outline the hippocampal formation, CA1 and the dentate gyrus (DG) used for 1340 
quantification of Parvalbumin-positive cells and cells expressing cleaved Caspase 3. b 1341 
Prefrontal cortex (PFC). The box indicates the region in which cell density was quantified. 1342 
The dotted line outlines the region in which Parvalbumin-positive cells and cells expressing 1343 





Supplementary Fig. 3 Brain structure visualised by Nissl staining. Sections through 1346 
hippocampus (HP) a, prefrontal cortex (PFC) b, and corpus callosum (CC) c, were stained 1347 
with Nissl to visualise cell bodies and tissue structure. scale bars, 100m in a and b, 500m 1348 




Stratum, Radiatum, Lacunosum and Moleculare, and PFC. Data were analysed by Kruskal-1350 
Wallis one-way ANOVA. Horizontal line on graphs, average of values for each sample; WT, 1351 
wild-type; HET, heterozygous Der1; HOM, homozygous Der1  1352 





Supplementary Fig. 4 Cortical layers visualised by Nissl staining. Barrel cortex was used to 1355 
examine layering in detail because the individual cortical layers could not be distinguished in 1356 
prefrontal cortex. Sections through barrel cortex (BC) a, and prefrontal cortex (PFC) b, were 1357 
stained with Nissl to visualise cell bodies and tissue structure. Cortical layers and 1358 
measurements taken are indicated. c Quantification of layer thickness in barrel cortex and 1359 
PFC. Two-way ANOVA found no effect of genotype on layer thickness (F1,40=0.1959, 1360 




barrel cortex. Unpaired two-tailed t-test found no effect of genotype on cortical thickness in 1362 
PFC (p=0.2). Horizontal line on graphs, average of values for each sample; scale bars, 1363 





Supplementary Fig. 5 No change in Parvalbumin-expressing interneuron density in Der1 1366 
prefrontal cortex. a Prefrontal cortex (PFC) sections from nine week old mouse brain were 1367 
stained with an antibody specific for Parvalbumin. Enlarged regions showing Parvalbumin-1368 
expressing interneurons are indicated by boxes. scale bars, 100m b Average density of 1369 
Parvalbumin-expressing interneurons from both sides of the brain. Data were analysed by 1370 
Kruskal-Wallis one-way ANOVA. Horizontal line on graphs, average of values for each 1371 
sample; WT, wild-type; HET, heterozygous Der1; HOM, homozygous Der1 1372 








Supplementary Fig. 6 Quantification of apoptotic cells. a Hippocampal (HP) sections from 1375 
nine week old mouse brain were stained with an antibody specific for Activated Caspase 3 1376 
and counterstained with Nuclear Fast Red. Enlarged regions showing apoptotic cells are 1377 
indicated by white boxes. b Average density of hippocampal apoptotic cells from both sides 1378 
of the brain. Hippocampus refers to the whole hippocampal formation. c Prefrontal cortex 1379 
(PFC) sections from nine week old mouse brain were stained with an antibody specific for 1380 
Activated Caspase 3 and counterstained with Nuclear Fast Red. Enlarged regions showing 1381 
apoptotic cells are indicated by boxes. d Average density of PFC apoptotic cells from both 1382 
sides of the brain. Data were analysed by Kruskal-Wallis one-way ANOVA, p=0.06 for CA1. 1383 
Horizontal line on graphs, average of values for each sample; WT, wild-type; HET, 1384 








Supplementary Fig. 7 Test deconvolution of the 24 Superset cell classes15. Reference 1387 
profiles were generated using stringent specificity value (SV) thresholds of 0.75 or 0.6 to 1388 
ensure that each cell class was represented by its most specific genes.  In silico samples 1389 
were created by mixing the thresholded gene expression profiles in proportions between 0 1390 
and 0.5. CIBERSORT input was compared to output and Pearson correlation coefficient and 1391 
R2 calculated to assess the quality of deconvolution of each artificial sample. 1392 






Supplementary Fig. 8 Deconvolution of heterozygous Der1 cortex and hippocampus 1396 
RNASeq data using the Superset cell class profiles15 as reference. Reference profiles were 1397 
generated using stringent specificity value (SV) thresholds of 0.75 or 0.6 to ensure that each 1398 
cell class was represented by its most specific genes. Note that although the proportions 1399 
change with the threshold set, and therefore the number of specific genes used for 1400 




Samples from embryonic cell types, neural progenitors and neuroblasts were not accurately 1402 
deconvolved by CIBERSORT, thus their apparently high levels in the wild-type and Der1 1403 
tissue are not an indication of true prevalence. Blue, wild-type; red, Der1 heterozygote; Emb, 1404 
embryonic 1405 








Supplementary Fig. 9 Der1 cortex gene dysregulation within the ‘Oxidative phosphorylation’ 1408 
canonical pathway. Pathway impairment was predicted by IPA based on gene dysregulation 1409 
at the whole gene level using DESeq2 data. Double outlines indicate protein complexes, the 1410 
components of which can be found in Supplementary Table 2a, b. Colour intensity 1411 
represents strength of gene expression change. green, downregulated; red, upregulated  1412 






Supplementary Fig. 10 Der1 cortex gene dysregulation within the ‘Fatty acid -oxidation I’ 1416 
canonical pathway. Pathway impairment was predicted by IPA based on gene dysregulation 1417 
at the whole gene level using DESeq2 data. Double outlines indicate enzyme complexes. To 1418 
provide additional information, genes encoding relevant dysregulated enzymes and a 1419 
transporter have been added to the pathway using the IPA ‘Build’ tool. Colour intensity 1420 
represents strength of gene expression change, with graded colour within double outlined 1421 
symbols representing overall direction of change within protein complexes. green, 1422 
downregulated; red, upregulated  1423 





Supplementary Fig. 11 Volcano plots showing differentially expressed synaptosomes 1426 
proteins in comparisons between Der1 mice and wild-type controls. No significant 1427 
differences were found after multiple testing correction in cortex from heterozygous and 1428 
homozygous Der1 mice, nor in hippocampus from heterozygous Der1 mice. In hippocampus 1429 
from homozygous Der1 mice, 62 proteins were found to be significantly dysregulated (FDR 1430 
adjusted p-value ≤ 0.05) as indicated by the coloured dots above the dashed line. 1431 
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